Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DISHMAN CARBOGEN AMCIS Plunges 12%; BSE HEALTHCARE Index Down 0.1%
Wed, 14 Aug 9:26

DISHMAN CARBOGEN AMCIS Plunges 12%; BSE HEALTHCARE Index Down 0.1%Image source: DNY59/www.istockphoto.com

DISHMAN CARBOGEN AMCIS share price has plunged 12% and is presently trading at Rs 172.8.

Meanwhile, the BSE HEALTHCARE index is at 41,000.5 (down 0.1%).

Among the top losers in the BSE HEALTHCARE index today are Divis Laboratories (down 2.2%) and ASTRAZENECA PHARMA (down 1.7%).

AJANTA PHARMA (up 6.4%) and ALEMBIC PHARMA (up 1.7%) are among the top gainers today.

Over the last one year, DISHMAN CARBOGEN AMCIS has moved up from Rs 157.8 to Rs 172.8, registering a gain of Rs 15.1 (up 9.5%).

On the other hand, the BSE HEALTHCARE index has moved up from 27,819.2 to 41,000.5, registering a gain of 47.4% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were GRANULES INDIA (up 129.7%), GSK Pharma (up 99.8%) and SUVEN PHARMACEUTICALS (up 98.5%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 78,980.1 .

The top gainers among the BSE Sensex today are Tech Mahindra (up 1.0%) and M&M (up 0.9%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.

In the meantime, NSE Nifty is at 24,146.7 . Hindalco and HCl Tech. are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,401.9 to 78,980.1, registering a gain of 13,578.2 points (up 20.8%).

DISHMAN CARBOGEN AMCIS Financial Update...

DISHMAN CARBOGEN AMCIS net profit grew 1.1% YoY to Rs -699 million for the quarter ended March 2024, compared to a loss of Rs 707 million a year ago. Net sales rose 5.8% to Rs 6,547 million during the period as against Rs 6,186 million in January-March 2023.

For the year ended March 2023, DISHMAN CARBOGEN AMCIS reported 265.5% decrease in net profit to Rs -298 million compared to net profit of Rs 180 million during FY22. Revenue of the company grew 12.7% to Rs 24,129 million during FY23.

The current Price to earnings ratio of DISHMAN CARBOGEN AMCIS, based on rolling 12 month earnings, stands at -17.7.


Equitymaster requests your view! Post a comment on "DISHMAN CARBOGEN AMCIS Plunges 12%; BSE HEALTHCARE Index Down 0.1%". Click here!